Metabolic and pharmacokinetic evaluation of a Novel 3-hydroxypyridinone iron chelator, CP502, in the rat Jasmina NovakovicAngelo TesoroMichael Spino OriginalPaper Pages: 221 - 224
Pharmacokinetics and dialysability of naltrexone in patients undergoing hemodialysis Nicolas K. KambiaThierry DineClaude Brunet OriginalPaper Pages: 225 - 230
Light induced changes in quinolone levels in rat serum and tissues Tesseromatis C.Kotsiou A.Vairactaris E. OriginalPaper Pages: 231 - 233
The normalization of total clearances for intravenous injection drugs Toshio NishiyamaShin Iguch OriginalPaper Pages: 235 - 236
The stability studies andin vitro hepatic microsomal metabolism of some α-phenyl-N-substituted nitrones in rats Gülen BulutMehmet OktavMert Ulgen OriginalPaper Pages: 237 - 248
In vitro mircosomal metabolism of N-benzyl and N-benzoylnornicotine derivates by rat F. YilmazF. Aricioĝlu KartalJohn W. Gorrod OriginalPaper Pages: 249 - 256
Human hepatic metabolism of the anxiolytic agent, RWJ-51521 — API-MS/MS identification of metabolites W. N. WuL. A. McKownA. B. Reitz OriginalPaper Pages: 257 - 262
Metabolism of the new nonbenzodiazepine anxiolytic agent, RWJ-51204, in mouse, rat, dog, monkey and human hepatic S9 fractions, and in rats, dogs and humans W. N. WuL. A. McKownA. B. Reitz OriginalPaper Pages: 263 - 268
Mechanism of the stimulatory effect of native fucoidan, highly sulfated fucoidan and heparin on plasminogen activation by tissue plasminogen activator: The role of chloride DeShawn LangTalya WilliamsV. M. Doctor OriginalPaper Pages: 269 - 275
